Position in IQV
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$579
+$68 QoQ
Shares Held
3
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,063
of 1,082 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tradewinds Capital Management, LLC holds $80,390 across 7 Diagnostics & Research names. IQV ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
170 | $47,600 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
42 | $21,057 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
9 | $4,737 | |
| 4 | GRAL |
GRAIL, Inc.
|
50 | $3,413 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
|
100 | $2,052 | |
| 6 | DHR |
Danaher Corp /De/
|
5 | $952 | |
| 7 | IQV |
Iqvia Holdings Inc.
This page
|
3 | $579 |
All Filings in IQV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $579 | 3 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $511 | 3 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $676 | 3 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $569 | 3 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $472 | 3 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $528 | 3 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $589 | 3 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $710 | 3 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $634 | 3 | Shares | Sole | 2024-07-18 | |
| No filing history on record for this holder in this stock. | ||||||